The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, today approved the clinical trial of the MVA-SARS-2-S vaccine against COVID-19. The vector vaccine was developed by
Scientists at the German Center for Infection Research (DZIF) are working at full speed on a vaccine against SARS-CoV-2. The vector vaccine is expected to enter the clinical phase I trial in September
Bonn, 6. August 2020. Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way
Prof. Dr. Christian Drosten, Director of Charité’s Institute of Virology and scientist in the German Center for Infection Research (DZIF), has been awarded the ‘Special Award for Outstanding
An important line of defence in the fight against the new corona virus SARS-CoV-2 is the formation of neutralising antibodies. These can eliminate the intruders and have great potential to be used for
